Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 17/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 16/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 12/20 | 0.54 |
| ▸ | HTR2B | P41595 | 6/20 | 0.54 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.54 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.54 |
| ▸ | HTR2C | P28335 | 3/20 | 0.54 |
| ▸ | TMIGD3 | P0DMS9 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19503864 | 0.93 | ADORA3 (0.69) | ADORA3ADORA1ADORA2AHTR2BTMEM97 | |
| SCHEMBL19807422 | 0.82 | ADORA3 (0.75) | ADORA3ADORA1ADORA2AHTR2BHTR2C | |
| SCHEMBL19503865 | 0.81 | ADORA3 (0.76) | ADORA3ADORA1ADORA2AHTR2BHTR2C | |
| SCHEMBL25565810 | 0.78 | ADORA3 (0.62) | ADORA3ADORA1ADORA2AHTR2BTMEM97 | |
| SCHEMBL25566681 | 0.78 | ADORA3 (0.71) | ADORA3ADORA1ADORA2AHTR2BHTR2C | |
| SCHEMBL25566672 | 0.78 | AHCY (0.56) | ADORA3ADORA1ADORA2AHSP90B1 | |
| SCHEMBL21939669 | 0.77 | ADORA3 (0.71) | ADORA3 | |
| SCHEMBL25566632 | 0.77 | ADORA3 (0.53) | ADORA3ADORA1ADORA2AHSP90B1TMIGD3 | |
| SCHEMBL21257353 | 0.76 | ADORA3 (0.65) | ADORA3ADORA1ADORA2AHTR2BTMEM97 | |
| SCHEMBL17243942 | 0.76 | AHCY (0.51) | ADORA3ADORA1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9181253-B2 | Adenosine receptor agonists, partial agonists, and antagonists | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2015-11-10 | — | — | US | disclosed |